Metabolomics Reveals Gut Microbiota Contribute to PPARα Deficiency-Induced Alcoholic Liver Injury

Area of Science:

• Hepatology
• Metabolomics
• Microbiome research

Background:

• Alcoholic liver disease (ALD) has high incidence and mortality rates globally.
• The role of peroxisome proliferator-activated receptor alpha (PPARα) in ALD pathogenesis is not fully understood.

Purpose of the Study:

• To investigate the effect of PPARα deficiency on alcohol-induced liver injury.
• To explore the underlying mechanisms involving lipid metabolism, urinary metabolome, and gut microbiota.

Main Methods:

• Utilized Ppara-null mice and wild-type mice subjected to ethanol feeding.
• Performed liver lipidomics, urinary metabolomics, and gut microbiota phylum-level analysis.
• Quantified specific bacterial genera (Clostridium_sensu_stricto_1, Romboutsia) and urinary metabolite 4-hydroxyphenylacetic acid (4-HPA).

Main Results:

• PPARα deficiency exacerbated ethanol-induced liver injury.
• Ethanol altered lipid species, urinary 4-HPA levels, and gut microbiota composition (increased Firmicutes, decreased Bacteroidetes) in Ppara-null mice.
• Upregulation of Clostridium_sensu_stricto_1 and Romboutsia was observed in Ppara-null mice after alcohol feeding.
• 4-HPA demonstrated potential to ameliorate ALD by modulating inflammation and lipid metabolism.

Conclusions:

• PPARα deficiency potentiates alcohol-induced liver injury via lipid accumulation, altered urinary metabolome, and specific gut bacterial changes.
• 4-hydroxyphenylacetic acid shows therapeutic potential for ALD.
• Targeting gut microbiota and their metabolites presents a novel therapeutic strategy for ALD.